According to the Organized Program to Initiate Lifesaving Treatment in Hospitalized HF Patients (OPTIMIZE-HF) study, the prescription rate of beta blockers at discharge was increased from 76.3% to 86.4% during the course of study while no change in the ACE inhibitor prescription rate was seen [24]. This evidence concerns the gene ACE and hydrops fetalis.